examples of highly selective diaryl ketone reductions involv-
ing hydrogenation or CBS reduction.7-9 The highly enanti-
oselective (>95% ee) reduction of select benzophenones has
been demonstrated by using lithium aluminum hydride-
chiral amino alcohol complexes,10,11 B-chlorodiisopinocam-
phenylborane,12 oxazaborolidine,13 and chiral diphosphine/
diamine Ru complexes.14 These types of chemically catalyzed
diaryl ketone reductions rely on both electronic and steric
effects to determine the degree of enantioselectivity. Their
limitation lies in the fact that their substrates must either be
highly electronically dissymmetric or have an ortho-
substituted aryl group to achieve good selectivity. For
example, the highly selective CBS reduction of ketone 1
takes advantage of the electron-donating and -accepting
groups on either end of the molecule, while the reduction of
ketone 2 demonstrates that the presence of an ortho sub-
stituent on one of the aryl groups provides sufficient steric
effect for excellent selectivity. Simple meta and para
substitutions resulted in moderate to no selectivity.13,15
run at low substrate loading (1 g/L) and many times lead to
low product yield (∼10%) due to difficulties in isolating the
product away from the cells.17
Isolated ketoreductase enzymes have been demonstrated
to be highly selective catalysts for the reduction of a wide
range of ketones.18 Additionally, many of these enzymes are
readily available and have been used to economically deliver
kilogram quantities of chiral intermediates with excellent ee
(>99%) and isolated yield (>90%).19,20
This work demonstrates a practical procedure for the
enantioselective reduction of diaryl ketones by using isolated
enzymes and its general application to a broad range of
substrates (Scheme 1). Each of the enzymes used for these
Scheme 1. KRED-Catalyzed Enantioselective Diaryl Ketone
Reduction
transformations required NADPH cofactor as the hydride
source, so an NADPH recycling system was put in place by
using glucose and a co-enzyme glucose dehydrogenase
(GDH) to regenerate the reduced form of the cofactor. The
presence of the recycle system also provides the driving force
to take these reactions to completion. Additionally, all of
the enzymes used for these transformations are readily and
economically available in large quantities from commercial
sources (Biocatalytics Inc.).
Figure 2 shows the range of diaryl ketone substrates that
were screened against our in-house library of commercially
available ketoreductases (KREDs). The range of substrates
includes ortho-, meta-, and para-substituted benzophenones
as well as several benzoylpyridines. Aryl substitutions
included electron-donating, electron-withdrawing, and halo-
gen substituents. Table 1 shows the results of the enzyme
catalyst screen with the highest ee obtained for each
enantiomer of the diarylmethanol products along with the
corresponding enzyme catalysts. Isolated yields are also
identified for select reactions that were demonstrated at the
1 g scale.
Figure 1. Highly selective CBS reduction of select diaryl ketones
Biological catalysts in the form of whole cells have been
shown to be extremely stereoselective in the reduction of
some diaryl ketones that are difficult to reduce with chemical
catalysts. Immobilized baker’s yeast catalyzed the reduction
of 2-benzoylpyridine in hexane to afford the alcohol with
high optical purity (96% ee).16 Selected strains from Hansen-
ula nonfermentans, santamariae, ernobii, Rhodosporidium
toruloides, Candida bombi, and sorbophila have also been
shown to reduce diaryl ketones with high selectivity,
producing alcohol product with >95% ee.5 Disadvantages
of whole cell biocatalytic systems are that they are typically
(7) Blaser, H.-U.; Malan, C.; Pugin, B.; Spindler, F.; Steiner, H.; Studer,
M. AdV. Synth. Catal. 2003, 345, 103-151.
(8) Corey, E. J.; Helal, C. J. Angew. Chem., Int. Ed. 1998, 37, 1986-
2012.
Generally, ortho-substituted substrates afforded greater
alcohol product ee than their meta- and para-substituted
counterparts. This trend was observed in methyl (3a, 3b, 3c),
hydroxy-, (3f, 3g, 3h), amino- (3i, 3j), and chloro- (3l, 3m,
(9) O’Shea, P. D.; Chen, C.-Y.; Chen, W.; Dagneau, P.; Frey, L.;
Grabowski, E. J. J.; Marcantonio, K. M.; Reamer, R. A.; Tan, L.; Tillyer,
R. D.; Roy, A.; Wang, X.; Zhao, D. J. Org. Chem. 2005, 70, 3021-3030.
(10) Brown, E.; Penfornis, A.; Bayma, J.; Touet, J. Tetrahedron:
Asymmetry 1991, 2, 339-342.
(11) Brown, E.; Leze, A.; Touet, J. Tetrahedron: Asymmetry 1992, 3,
841-844.
(17) Chartrain, M.; Lynch, J.; Choi, W.-B.; Churchill, H.; Patel, S.;
Yamazaki, S.; Volante, R.; Greasham, R. J. Mol. Catal. B: Enzym. 2000,
8, 285-288.
(12) Shieh, W.-C.; Cantrell, W. R.; Carlson, J. A. Tetrahedron Lett. 1995,
36, 3797-3800.
(18) Kaluzna, I.; Rozzell, D.; Kambourakis, S. Tetrahedron: Asymmetry
2005, 16, 3682-3689.
(13) Corey, E. J.; Helal, C. J. Tetrahedron Lett. 1996, 37, 5675-5678.
(14) Ohkuma, T.; Koizumi, M.; Ikehira, H.; Yokozawa, T.; Noyori, R.
Org. Lett. 2000, 2, 659-662.
(19) Truppo, M.; Kim, J.; Brower, M.; Madin, A.; Sturr, M.; Moore, J.
J. Molec. Catal. B: Enzym. 2006, 38, 158-162.
(15) Corey, E. J.; Helal, C. J. Tetrahedron Lett. 1995, 36, 9153-9156.
(16) Takemoto, M.; Achiwa, K. Chem. Pharm. Bull. 1994, 42, 802.
(20) Pollard, D.; Truppo, M.; Pollard, J.; Cheng-Yi, C.; Moore, J.
Tetrahedron: Asymmetry 2006, 17, 554-559.
336
Org. Lett., Vol. 9, No. 2, 2007